American Capital Management Inc. Buys 13,033 Shares of Azenta, Inc. (NASDAQ:AZTA)

American Capital Management Inc. boosted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 4.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 340,501 shares of the company's stock after buying an additional 13,033 shares during the period. American Capital Management Inc. owned approximately 0.70% of Azenta worth $16,494,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of AZTA. Verition Fund Management LLC acquired a new stake in shares of Azenta during the 3rd quarter worth approximately $873,000. Glenmede Trust Co. NA lifted its stake in Azenta by 6.3% during the third quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock worth $551,000 after purchasing an additional 679 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Azenta by 285.8% in the 3rd quarter. BNP Paribas Financial Markets now owns 31,227 shares of the company's stock valued at $1,513,000 after purchasing an additional 23,132 shares in the last quarter. Cerity Partners LLC increased its stake in shares of Azenta by 21.2% in the 3rd quarter. Cerity Partners LLC now owns 39,031 shares of the company's stock valued at $1,891,000 after purchasing an additional 6,840 shares during the last quarter. Finally, Commerce Bank raised its holdings in shares of Azenta by 42.8% during the 3rd quarter. Commerce Bank now owns 18,097 shares of the company's stock worth $877,000 after buying an additional 5,428 shares in the last quarter. 99.08% of the stock is owned by institutional investors.

Azenta Stock Down 1.9 %

Shares of AZTA stock traded down $0.90 during mid-day trading on Friday, reaching $46.21. 445,381 shares of the stock traded hands, compared to its average volume of 1,252,499. The company has a market cap of $2.26 billion, a price-to-earnings ratio of -15.56 and a beta of 1.48. The stock's fifty day simple moving average is $44.95 and its two-hundred day simple moving average is $49.88. Azenta, Inc. has a 1-year low of $38.82 and a 1-year high of $69.16.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. The business had revenue of $170.00 million for the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The firm's revenue was down 1.2% compared to the same quarter last year. During the same period last year, the company earned $0.13 EPS. On average, equities research analysts anticipate that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AZTA. Needham & Company LLC reduced their price objective on Azenta from $69.00 to $55.00 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Evercore ISI reduced their price target on shares of Azenta from $53.00 to $50.00 and set an "in-line" rating on the stock in a research note on Tuesday, October 1st. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Azenta has an average rating of "Hold" and an average target price of $63.60.

Insider Activity at Azenta

In related news, CEO John Marotta bought 12,717 shares of Azenta stock in a transaction that occurred on Monday, November 18th. The shares were acquired at an average cost of $39.48 per share, for a total transaction of $502,067.16. Following the completion of the acquisition, the chief executive officer now directly owns 99,612 shares of the company's stock, valued at approximately $3,932,681.76. The trade was a 14.63 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director William L. Cornog purchased 12,500 shares of the stock in a transaction on Monday, November 18th. The shares were purchased at an average price of $39.60 per share, with a total value of $495,000.00. Following the acquisition, the director now owns 14,755 shares in the company, valued at approximately $584,298. The trade was a 554.32 % increase in their position. The disclosure for this purchase can be found here. Insiders sold 3,018 shares of company stock worth $126,689 over the last three months. Company insiders own 1.77% of the company's stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.